SCHEMBL29567237

SCHEMBL29567237

Cc1ccccc1Oc1cc(C2(c3ccccc3)CC2)nc(N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 2/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAP4K4 O95819 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ ACHE P22303 4/20 0.37
▸ BCHE P06276 3/20 0.37
▸ PDPK1 O15530 2/20 0.37
▸ SLC6A2 P23975 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309720 1.00 NUDT1 (0.43) NUDT1SMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL24309324 0.79 NUDT1 (0.47) NUDT1SMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL26807641 0.78 TSHR (0.48) SMN1; SMN2ALDH1A1HPGDKMT2AMEN1
SCHEMBL29566520 0.72 HTR1A (0.38) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL24309722 0.72 HTR1A (0.38) SMN1; SMN2ALDH1A1KMT2AMEN1TSHR
SCHEMBL24309816 0.72 NUDT1 (0.43) NUDT1SMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL29566989 0.72 NUDT1 (0.43) NUDT1SMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL24310321 0.72 NUDT1 (0.43) NUDT1SMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL24309724 0.71 — —
SCHEMBL2724248 0.71 HSP90AA1 (0.47) SMN1; SMN2CYP1A2KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback